Europe

January 4, 2021January 4, 2021

EU Reviewing Zeposia as Ulcerative Colitis Treatment for Adults

The anti-inflammatory medication Zeposia (ozanimod) is under review in the European Union as a treatment for adults with moderately to severely active ulcerative colitis. The European Medicines Agency has validated ... Read more

November 6, 2019November 6, 2019

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

News

A new public-private initiative brings academic and industry researchers from 15 European countries together in a large-scale effort to understand differences and commonalities in seven immune-mediated and inflammatory diseases, including ... Read more

September 5, 2018September 5, 2018

Investigational ABX464 Enhances Remission Rates, Mucosal Healing in Ulcerative Colitis Patients in Phase 2a Trial

News

Abivax‘s small, anti-inflammatory molecule ABX464 significantly increased clinical remission and mucosal healing over placebo in patients with moderate to severe active ulcerative colitis resistant to other therapies, top-line results from a ... Read more

October 21, 2016October 21, 2016

German Program Aims to Help Young IBD Patients Move Safely to Adult Care

News

A new way of transitioning pediatric inflammatory bowel disease (IBD) patients to adult care — known as the Berliner Transitions Programme (BTP) — is being presented as way to improve patient quality of life by focusing ... Read more

November 13, 2014November 13, 2014

GI Cancer Becomes Leading Cause of Cancer Death in Europe

Colon Cancer, News

Gastrointestinal (GI) cancer is the new leading cause death by cancer in Europe, according to a major pan-European survey commissioned by United European Gastroenterology (UEG), which revealed several trend alterations regarding both GI and liver diseases as ... Read more